Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

279.98
Delayed Data
As of Apr 26
 -6.91 / -2.41%
Today’s Change
205.42
Today|||52-Week Range
307.33
+7.19%
Year-to-Date

Today’s Trading

Previous close286.89
Today’s open285.28
Day’s range279.57 - 286.62
Volume2,146,665
Average volume (3 months)1,645,168
Market cap$62.0B
Dividend yield--
Data as of 04/26/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.60%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+9.37%
P/E ratio16.5
Price/Sales6.09
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.10+1.64%
ILMNIllumina Inc+3.08+1.70%
BIVVBioverativ Inc+0.16+0.28%
NBIXNeurocrine Bioscienc...-0.34-0.63%
Data as of 04/26/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$5.21
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs